A highly experienced Drug Discovery and Development scientist and manager responsible for the non-clinical DMPK/ADME and in vitro Safety assessment of Roche’s Pharma Research and Early Development global portfolio. Key driver in building a highly efficient and innovative DMPK and Predictive/Mechanistic Safety organization for various modalities. Member of a decision body deciding on advancement of compounds into clinical development. Experienced in leading cross-functional and global teams.
